Lipin 3 Antibody [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # AF4064A

Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Immunocytochemistry, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant mouse Lipin 3
Thr428-Arg529
Accession # Q99PI4
Thr428-Arg529
Accession # Q99PI4
Specificity
Detects mouse Lipin 3 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 50% cross-reactivity with recombinant human (rh) Lipin 3 is observed and less than 5% cross-reactivity with rhLipin 1 and rhLipin 2 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Lipin 3 Antibody [Allophycocyanin]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Lipin 3
Long Name
Phosphatidate Phosphatase LPIN3
Alternate Names
LIPN3L, LPIN3, SMP2
Gene Symbol
LPIN3
Additional Lipin 3 Products
Product Documents for Lipin 3 Antibody [Allophycocyanin]
Product Specific Notices for Lipin 3 Antibody [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...